Spero Therapeutics
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Spero Therapeutics's balance sheet done over the years? Its assets were worth $182,390,000 last year, which is more than in the previous period. 41% of Spero Therapeutics’s total assets is currently financed by debt. Its liabilities reached the amount of $75,496,000, which means an increase by 54% compared compared to last year.
Debt to Assets
| 2015 | 7176000 | 7.43M | 103.58% |
|---|---|---|---|
| 2016 | 13772000 | 7.41M | 53.81% |
| 2017 | 93479000 | 8.52M | 9.12% |
| 2018 | 129006000 | 13.15M | 10.19% |
| 2019 | 106103000 | 31.52M | 29.72% |
| 2020 | 153451000 | 21.41M | 13.95% |
| 2021 | 171072000 | 82.78M | 48.39% |
| 2022 | 124802000 | 48.86M | 39.16% |
| 2023 | 182390000 | 75.49M | 41.39% |
SPRO Balance Sheet (2015 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||
Current assets: | |||||||||
Cash and cash equivalents | 76.33M | 109.10M | 112.58M | 85.20M | 29.73M | 34.08M | 87.28M | 10.31M | 5.69M |
Short term investments | 0 | 0 | 33.81M | 41.69M | 52.31M | 81.36M | 0 | 0 | 0 |
Net receivables | 50.69M | 1.08M | 2.64M | 6.17M | 8.54M | 1.29M | 2.94M | 304K | 10K |
Inventory | 0 | -4.46M | 0 | -12.23M | -13.36M | -8.77M | -4.77M | 0 | 0 |
Other current assets | 4.17M | 3.37M | 8.82M | 6.06M | 4.82M | 7.47M | 3.65M | 1.25M | 287K |
Total current assets | 131.20M | 109.10M | 157.87M | 126.90M | 82.04M | 115.44M | 87.28M | 11.87M | 5.98M |
Non-current assets: | |||||||||
Property, Plant and Equipment | 4.15M | 5.49M | 7.55M | 8.78M | 7.14M | 2.89M | 1.16M | 1.5M | 949K |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term investments | 0 | 0 | 0 | 0 | 21K | 0 | 50K | 0 | 50K |
Other non-current assets | 47.02M | 10.20M | 5.64M | 17.76M | 16.88M | 10.67M | 4.97M | 400K | 189K |
Total non-current assets | 51.18M | 15.69M | 13.2M | 26.54M | 24.05M | 13.56M | 6.19M | 1.9M | 1.18M |
Total assets | 182.39M | 124.80M | 171.07M | 153.45M | 106.10M | 129.00M | 93.47M | 13.77M | 7.17M |
Liabilities | |||||||||
| Current liabilities: | |||||||||
Accounts payable | |||||||||
Deferred revenue | 27.11M | 10.36M | 1.85M | 0 | 0 | 0 | 0 | 0 | 512K |
Short term debt | 3.43M | 1.69M | 1.36M | 947K | 928K | 0 | 0 | 0 | 0 |
Total current liabilities | 37.15M | 21.64M | 18.67M | 14.34M | 26.66M | 12.31M | 8.15M | 6.91M | 6.42M |
| Non-current liabilities: | |||||||||
Long term debt | 3.82M | 4.95M | 5.97M | 6.89M | 4.61M | 0 | 0 | 0 | 0 |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 23.69M | 96K | 48.55M | 177K | 249K | 833K | 365K | 493K | 1.01M |
Total non-current liabilities | 38.34M | 27.21M | 64.11M | 7.06M | 4.86M | 833K | 365K | 493K | 1.01M |
Total liabilities | 75.49M | 48.86M | 82.78M | 21.41M | 31.52M | 13.15M | 8.52M | 7.41M | 7.43M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |